XML 90 R40.htm IDEA: XBRL DOCUMENT
v3.25.4

Equity Method Investment (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Equity Method Investments | Summary Worldpay financial information is as follows (in millions):
|  |  | Eleven months
| Year ended |  | ended
Statement of Earnings (Loss) | December 31, 2025 |  | December 31, 2024
Revenue | $ | 5,476 |  |  | $ | 4,732 |
Gross profit | $ | 2,687 |  |  | $ | 2,422 |
Earnings (loss) before income taxes | $ | (434) |  |  | $ | (342) |
Net earnings (loss) attributable to Worldpay | $ | (496) |  |  | $ | (444) |
FIS share of net earnings (loss) attributable to Worldpay, net of tax (1) | $ | (526) |  |  | $ | (145) |
(1)For the year ended December 31, 2025, and eleven months ended December 31, 2024, this amount is net of $(307) million and $67 million, respectively, of investor-level tax benefit (expense), as well as intra-entity eliminations for timing differences between the Company and Worldpay's recognition of profits and losses on related-party transactions. The investor-level tax for the year ended December 31, 2025, includes $383 million of expense related to an increase to our deferred tax liability. This remeasurement resulted from our agreement to sell our remaining interest in Worldpay, which constituted a change in our intent to hold the investment for the long term, as well as our best estimate of the ordinary versus capital characterization of the expected proceeds. In accordance with the provisions of ASC 740, the deferred tax liability recognized in connection with our Worldpay equity method investment reflects the difference between the investment's current book value and its tax basis. As discussed in Note 1, the 2026 Worldpay Minority Interest Sale was completed on January 9, 2026, and the tax due will be based on the excess of sales proceeds over the tax basis and a number of other factors, including the valuation of assets held in Worldpay, how the form of the transaction was effectuated and the final purchase price allocation. The continued assessment of these factors and their potential impact on the ordinary versus capital characterization of the expected proceeds could result in a material change to the realizability of the deferred tax assets for U.S. capital loss carryforwards and the final tax computed on the sale.
| December 31,
Balance Sheet | 2025 |  | 2024
Current assets | $ | 8,744 |  |  | $ | 8,126 |
Noncurrent assets | $ | 15,642 |  |  | $ | 15,834 |
Current liabilities | $ | 6,643 |  |  | $ | 5,979 |
Noncurrent liabilities | $ | 9,419 |  |  | $ | 9,321 |
Noncontrolling interest | $ | — |  |  | $ | 1 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration